Skip to main content
Signal8

Solventum Corp (SOLV)

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Instruments & Supplies

Solventum Corporation logo

Solventum Corporation

NYSE:SOLVHealthcare
-2.33%$85.41
AH Close$85.41+0.00%vs close
Mkt Cap$14.54B
Float169.82M
O/S170.22M
Inst Own74.9%
Dilution
Historical Data
DateOpenHighLowCloseVolume
Key Metrics
Market Cap$14.54B
Enterprise Value--
P/E Ratio--
Est. Net Cash/Share--
Institutional Ownership74.91%

based on 170.22M shares outstanding

SectorHealthcare
IndustryMedical - Instruments & Supplies
ExchangeNYSE
CountryUSUS
IPO DateApr 1, 2024
Shares Outstanding170.22M
Float169.82M
Company Overview

Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients.

The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes.

Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.

Leadership

Bryan Hanson

Chief Executive Officer & Director

Carrie S. Cox

Chair of the Board; Chair of the board

Dr. Bernard A. Harris Jr.

Chief Executive Officer and Managing Partner, Versalius Ventures, Inc.; Director

Heather L. Knight

Chief Commercial Officer

Employees

21K+

Country

US

Sector

Healthcare

Website

solventum.com

Analyst Coverage
Analyst Coverage
ConsensusBuy
Price Target
No price targets available
Ratings Distribution
BUY
7
HOLD
3
SELL
1
TOTAL11
Insider Trading
InsiderTypeShares
Hanson Bryan C profile photoHanson Bryan CAutomatic Sell26.5K
Hanson Bryan C profile photoHanson Bryan COption Exercise67.3K
Hanson Bryan C profile photoHanson Bryan COption Exercise67.3K
Zieselman Neil Craig profile photoZieselman Neil CraigGrant/Award6.9K
Harris Bernard A Jr profile photoHarris Bernard A JrGrant/Award3.3K
MAY KAREN J profile photoMAY KAREN JGrant/Award3.3K
Shareholders
74.9%
Institutional
(890)
0.3%
Insiderⓘ
(20)
15.0%
5%+ Owners
(1)
9.8%
Unattributed (incl. retail)ⓘ
Institutional74.9%
Insider0.3%
5%+ Beneficial15.0%
Unattributed (incl. retail)9.8%
Sources: 13F, Form 4, 13D/13GO/S: 170.2M · as of 31 Jul 2026 · SEC cover page
Insiders & Institutional Holders
52-Week Range
$62.38$94.16
$85.41(72nd percentile)
Volume
Average Daily Volume990.93K
1.66M today vs 990.93K avg(+67%)

30d Avg

990.93K

60d Avg

936.87K

90d Avg

1.07M

Earnings
Dividend History
No dividend history available
Compliance Status
Loading compliance data...